OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted and immunotherapy in the era of personalised gastric cancer treatment
Silvia Catanese, Florian Lordick
Best Practice & Research Clinical Gastroenterology (2021) Vol. 50-51, pp. 101738-101738
Closed Access | Times Cited: 22

Showing 22 citing articles:

Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
Yongji Zeng, Ramon U. Jin
Seminars in Cancer Biology (2021) Vol. 86, pp. 566-582
Open Access | Times Cited: 125

Current therapies and progress in the treatment of advanced gastric cancer
Hongyu Li, Ming Shen, Shihao Wang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9

Stem Cells, Helicobacter pylori, and Mutational Landscape: Utility of Preclinical Models to Understand Carcinogenesis and to Direct Management of Gastric Cancer
Dylan Liabeuf, Masanobu Oshima, Daniel E. Stange, et al.
Gastroenterology (2021) Vol. 162, Iss. 4, pp. 1067-1087
Open Access | Times Cited: 36

Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
Floriana Nappo, Lorenzo Fornaro, Luca Pompella, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6601-6611
Open Access | Times Cited: 16

Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
Yuling Bin, Hongsai Hu, Feng Tian, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 20

Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu, Bhavani Sowndharya Balamurugan, Sundaram Vickram, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

Personalized Drug Treatment
Abhirup Khanna, Sapna Jain
(2024), pp. 295-319
Closed Access | Times Cited: 3

Global research trends on precision oncology: A systematic review, bibliometrics, and visualized study
Baoyue Zhang, Bo Ao, Xinyue Lu, et al.
Medicine (2022) Vol. 101, Iss. 43, pp. e31380-e31380
Open Access | Times Cited: 12

Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice
V. Fanotto, Francesca Salani, Caterina Vivaldi, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 900-900
Open Access | Times Cited: 7

Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer
Ya-Kun Jiang, Wěi Li, Ying-Yang Qiu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2318-2334
Open Access | Times Cited: 2

Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production
Yan Xia, Xiaolu Wang, Jie Lin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model
Xu-Xu He, Bang Du, Tao Wu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1268-1280
Open Access | Times Cited: 2

Effects and prognostic values of miR-30c-5p target genes in gastric cancer via a comprehensive analysis using bioinformatics
Shangshang Hu, Huaifeng Liu, Jinyan Zhang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8

Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology
Caterina Vivaldi, V. Genovesi, Clara Ugolini, et al.
Oncology (2023) Vol. 102, Iss. 2, pp. 157-167
Closed Access | Times Cited: 3

Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS–STAT3 pathway
Di Chen, Xinyue Wei, Yang Ke, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 4, pp. 030006052210933-030006052210933
Open Access | Times Cited: 4

Modern Treatment Strategies for Advanced Gastric Cancer: Comprehensive Evaluation and Future Directions
燕秋 文
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 02, pp. 199-205
Open Access

DUOX2, a New Biomarker for Disseminated Gastric Cancer’s Response to Low Dose Radiation in Mice
Palak R. Parekh, Eduardo Solano-Gonzàlez, Mariana Bonjiorno Martins, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4186-4186
Open Access | Times Cited: 1

Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
Irene Pecora, Clara Ugolini, Riccardo Giannini, et al.
Oncology (2023) Vol. 101, Iss. 7, pp. 435-445
Closed Access

Immunotherapy in upper gastrointestinal malignancies
Miroslav Žiaran
Onkologie (2022) Vol. 16, Iss. 3, pp. 123-126
Closed Access

Page 1

Scroll to top